119.2K
Downloads
255
Episodes
Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization.
Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist consulting firms. Our host Raman is an entrepreneur, investor, bestselling author, speaker and long time industry insider.
Episodes
Friday Jun 25, 2021
Friday Jun 25, 2021
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Urvish Pandya, Managing Director at Allotrope Scientific Ltd.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Urvish, covering:
- The exponential growth of chemistry in India leading to the production of many fine Indian chemists all over the world.
- Honest advice on how to deal with being made redundant as a result of being caught in the crossfire of M&A in the outsourcing space.
- The role of guiding drug sponsors in finding the right CRO and CDMO match, then getting the best out of them as a partner.
- The need for more modular and flexible capabilities in later stages of the drug manufacturing process.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.
No comments yet. Be the first to say something!